✦ LIBER ✦

Clinical stage I & II diffuse large-cell lymphoma: results of combined modality therapy and prognostic factor analysis

✍ Scribed by M.K. Gospodarowicz; R.W. Tsang; W. Wells; M. Pintilie; D. Hodgson; B. Patterson; M. Crump

Book ID: 108434630
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 27 KB
Volume: 51
Category: Article
ISSN: 0360-3016
DOI: 10.1016/s0360-3016(01)02495-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic factors in stage I and II dif

Prognostic factors in stage I and II diffuse large cell lymphoma patients treated with multiagent chemotherapy alone or combined with radiation therapy

✍ Timothy D. Shafman; Clair J. Beard; Barbara Silver; Peter Mauch 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 107 KB

Combined modality therapy for clinical s

Combined modality therapy for clinical stage I and II primary mediastinal large B-cell lymphoma treated at the Princess Margaret hospital

✍ A Sun; R Tsang; M Pintilie; M Gospodarowicz; W Wells; D Hodgson; M Crump; B Patt 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 30 KB

Management of stage I–II diffuse aggress

Management of stage I–II diffuse aggressive non-hodgkin's lymphoma of the waldeyer's ring: Combined modality therapy versus radiotherapy alone

✍ R. Liang; R. P. Ng; D. Todd; D. Choy; R. K. K. Khoo; F. C. S. Ho 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 494 KB

Twenty five patients with stage I and I1 diffuse aggressive non-Hodgkin's lymphoma of the Waldeyer's ring were reviewed. There were 19 patients with diffuse histiocytic, 4 diffuse lymphocytic poorly differentiated and 2 diffuse mixed lymphoma. Their median age was 51 years. There were 12 males and 1

MACOP-B ± radiation therapy for diffuse

MACOP-B ± radiation therapy for diffuse large cell lymphoma. Analysis of the Stanford Results According to Prognostic Indices

✍ Nancy L. Bartlett; Larry W. Kwak; Sandra J. Horning 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 833 KB